NAD+-DPR: A Potential Drug Target and Biomarker for Diseases (P8824)

Target Name: NAD-Dependent Protein Deacetylase

NCBI ID: P8824

Other Name(s): None

NAD+-DPR: A Potential Drug Target and Biomarker for Diseases

NAD-Dependent Protein Deacetylase (NAD+-DPR) is a protein that is involved in the process of protein synthesis and degradation. It is a key player in the regulation of protein homeostasis, and is essential for the proper functioning of many cellular processes. NAD+-DPR has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

The NAD+-DPR enzyme is a key player in the regulation of protein synthesis and degradation. It is a protein that is involved in the process of protein synthesis, which is the process by which cells build and repair proteins. NAD+-DPR is essential for the proper functioning of protein synthesis, as it helps to ensure that the amino acids that are used to build proteins are properly attached to the protein.

NAD+-DPR is also involved in the regulation of protein degradation. This is the process by which cells remove damaged or unnecessary proteins from their cells. NAD+-DPR is essential for the proper functioning of protein degradation, as it helps to ensure that proteins that are no longer needed are properly removed from the cell.

In recent years, NAD+-DPR has been identified as a potential drug target for a variety of diseases. For example, NAD+-DPR has been shown to be involved in the regulation of cancer cell growth, and has been identified as a potential therapeutic target for cancer. Additionally, NAD+-DPR has been shown to be involved in the regulation of neurodegenerative diseases, and has been identified as a potential therapeutic target for these conditions.

In addition to its potential therapeutic applications, NAD+-DPR has also been identified as a potential biomarker for a variety of diseases. For example, NAD+-DPR has been shown to be involved in the regulation of muscle strength and function, and has been identified as a potential biomarker for muscle diseases. Additionally, NAD+-DPR has been shown to be involved in the regulation of metabolism, and has been identified as a potential biomarker for metabolic disorders.

Overall, NAD+-DPR is a protein that is involved in the regulation of protein synthesis and degradation. It is a key player in the regulation of protein homeostasis, and is essential for the proper functioning of many cellular processes. As a result, NAD+-DPR has been identified as a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of NAD+-DPR in the regulation of protein synthesis and degradation, and to develop effective treatments for the conditions associated with its dysfunction.

Protein Name: NAD-Dependent Protein Deacetylase (nonspecified Subtype)

More Common Targets